The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, April 22, 2025.
Nathan Posner | Anadolu | Getty Images
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, according to a memo seen by CNBC, days after the departure of former commissioner Marty Makary.
Acting director of the FDA’s Center for Drug Evaluation and Research Tracy Beth Høeg and acting director of the Center for Biologics Evaluation and Research Katherine Szarama will leave their roles, according to the memo. The two divisions are responsible for regulating prescription drugs, including pills and vaccines.
Szarama will remain at the agency, according to the memo. Høeg in a post on X said she was fired. Karim Mikhail will replace Høeg at CDER and Michael Davis will replace Szarama at CBER. Lowell Zeta will take over as acting chief of staff. As of Friday night, an organization chart on the the FDA’s website had been updated to reflect those changes.
The shake up caps a tumultuous week at the FDA, which is responsible for regulating products that account for some 20% of consumer spending in the U.S. Makary resigned after days of reports that President Donald Trump wanted to oust the commissioner. And it’s the latest shuffle at an agency that’s struggled with turnover under the second Trump administration.
Davis becomes the fifth person to lead CDER since last January. CBER has also seen multiple faces in the job over the past year, including Vinay Prasad, who left the division then returned only to leave again after a series of controversies.
The Trump administration hopes to name a new nominee for permanent commissioner in a matter of weeks, the senior administration official told CNBC this week. That person would need to be confirmed by the Senate. Meanwhile, the Trump administration is trying to fill health vacancies, including the director for the Centers for Disease Control and Prevention and the surgeon general.
Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.FDA shuffles top drug, biologics leaders in latest shakeup NYT News Today.
Hence then, the article about fda shuffles top drug biologics leaders in latest shakeup was published today ( ) and is available on NY Times News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA shuffles top drug, biologics leaders in latest shakeup )
Also on site :
- Potato futures are soaring – should the world be worried?
- Starbucks to Cut 300 Jobs— Here's How to Handle a Layoff According to a Pro
- Fijan en US$ 1,2 millones la fianza de Chud the Builder, streamer conocido por contenidos racistas detenido tras tiroteo